Bruce Booth - Insider Trading & Ownership

Entity
Individual
Location
890 Winter Street, Suite 320, Waltham, MA
Summary
The estimated net worth of Bruce Booth is at least $50.4M dollars as of July 9, 2024. Bruce Booth is the Director of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $28.4M. Bruce Booth is the Director of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $22M.
All Insider Reports
All Insider Reports

Ownership of Bruce Booth

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KYMR Kymera Therapeutics, Inc. Director $28.4M -$38.3M -57.5% Jul 9, 2024
VIGL Vigil Neuroscience, Inc. Director $22M Jun 5, 2024
TECX Tectonic Therapeutic, Inc. Director Jun 6, 2023
DNTH Dianthus Therapeutics, Inc. /DE/ Director Jun 28, 2022

Insider Transactions Reported by Bruce Booth:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.